Cumberland Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.04-$7.25 |
Market Cap | $61.6M |
Shares Short | 293,183 |
Financials
See moreRevenue (12 Mos) | $37.8M |
Revenue Growth (YoY) | 11.6% |
Gross Profit (12 Mos) | $31.2M |
Diluted EPS | -$0.46 |
About
CEO | Mr. A. J. Kazimi MBA |
CFO | Mr. John Michael Hamm C.M.A. |
Address | 1600 West End Avenue, Nashville, TN, United States, 37203 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 91 |
